USPTO Patent Grants - Peptides (C07K)
Granted patents in USPTO classification C07K, covering peptides, proteins, antibodies, and related biological molecules. Around 160 grants a month, each with the patent number, title, applicant, inventor names, and full abstract. Unlike published applications (which reveal in-progress research), grants are enforceable rights and signal what a company can now litigate or license. Watch this if you run an antibody or protein biologics program, advise on patent portfolio strategy for biologics companies, scout for licensing opportunities on recently granted claims, or track which research institutions are converting their early peptide work into issued patents.
Tuesday, March 24, 2026
USPTO Patent Granted for Anti-Pro/Latent Myostatin Antibodies
The USPTO has granted a patent (US12582712B2) to Scholar Rock, Inc. for a method of making anti-pro/latent myostatin antibodies. The patent covers antibodies that specifically bind proMyostatin and/or latent Myostatin and their uses.
Amgen Inc. Patent for KRAS G12C Inhibitor Cancer Therapy
The USPTO has granted Amgen Inc. a patent (US12582657B2) for a combination therapy involving a KRAS G12C inhibitor and other agents for treating cancers. The patent covers pharmaceutical compositions and methods of treatment.
Sunday, March 22, 2026
USPTO Grants Patent for Single Molecule Peptide Sequencing
The USPTO has granted a patent (US12578345B2) to The University of Texas System for methods of single molecule peptide sequencing. The patent covers techniques for identifying polypeptide sequences within a mixture by immobilizing, labeling, and analyzing the polypeptide.
USPTO Patent for Alzheimer's Detection Kits
The USPTO has granted a patent (US12578344B2) to NEUROQUEST LTD. for compositions, kits, and methods for detecting preclinical Alzheimer's Disease. The patent covers binding agents for biomarkers such as CD163 and scavenger receptors, and methods for diagnosing AD and assessing therapeutic efficacy.
USPTO Patent Grant: Canine TK1 Protein Determination Kit
The USPTO has granted patent US12578340B2 to ALERTIX VETERINARY DIAGNOSTICS AB for a kit to determine canine TK1 protein levels. The kit utilizes specific monoclonal antibodies to detect peptides from canine TK1.
USPTO Patent Grant for Polypeptide Reagent Kit
The USPTO has granted a patent (US12578329B2) to Shimadzu Corporation for a reagent kit containing polypeptides designed for detecting intermolecular interactions. The patent details specific amino acid sequences and their modifications for use in this kit.
Microsoft Technology Licensing, LLC Awarded Patent for Anti-lock Hinged Device
The USPTO has granted Microsoft Technology Licensing, LLC a patent for an anti-lock hinged device. The patent, US12577979B2, describes a mechanism designed to prevent over-extension in hinged devices. The filing date for this patent application was October 23, 2023.
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source details
Activity
Browse Categories
Get USPTO Patent Grants - Peptides (C07K) alerts
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.